AI assistant
Sending…
Monopar Therapeutics — Director's Dealing 2019
Dec 21, 2019
32883_dirs_2019-12-20_e732a5af-e660-4993-be84-108064a3852a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Monopar Therapeutics (MNPR)
CIK: 0001645469
Period of Report: 2019-12-18
Reporting Person: Tsuchimoto Kim R (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-18 | Common stock | P | 325 | $8.00 | Acquired | 325 | Direct |